TELUM THERAPEUTICS
Live / Applied — Non-final action written — not yet mailed (as of 04 Nov 2026)
What this means for you
Not registered yet, but its 03 Jul 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79461504
- Mark type
- Design + words
- Filed
- 03 Jul 2026
Goods and services
- Class 001 — Chemicals: Diagnostic products for scientific use; reagents for medical research; Reagents for medical research in the field of infectious diseases and diseases caused by bacteria; diagnostic reagents for scientific use or for research; Enzymes for scientific use; diagnostic kits for scientific use comprising specimen receptacles and reagents for analyzing selected bacteria.
- Class 005 — Pharmaceuticals: Pharmaceutical products for infectious disease treatment; pharmaceutical products for treatment of diseases caused by bacteria; Antibacterial pharmaceutical products; antibiotics; Biopharmaceuticals for infectious disease treatment; immunotherapeutic agents for bacterial infections; Enzyme preparations for medical use; enzymes for medical use; Enzymes and enzyme preparations for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; tests, biomarkers and reagents for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria.
- Class 042 — Scientific and technological services: Biomedical research services; scientific research for medical purposes in the field of infectious diseases and diseases caused by bacteria; Research and development of pharmaceutical products, antibiotics, tests, biomarkers and reagents for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; research and development of immunotherapeutic agents for bacterial infections; Research and development of enzymes, enzyme preparations and synthetic proteins for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; clinical trials for pharmaceutical products, antibiotics, tests, biomarkers and reagents for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; Software as a Service [SaaS]; Platform as a Service [PaaS]; Artificial Intelligence as a Service [AIaaS].
Owner
Prosecution history
- 04 Nov 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 04 Nov 2026 — NON-FINAL ACTION WRITTEN
- 03 Nov 2026 — ASSIGNED TO EXAMINER
- 29 Oct 2026 — APPLICATION FILING RECEIPT MAILED
- 29 Oct 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 Oct 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB